Number of the records: 1
Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells
Title Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells / J. Duraj ... [et al.] Another responsib. Duraj, J. (Author) Hunáková, Ľubica (Author) Boďo, Juraj (Author) Jakubíková, Jana (Author) Chovancová, Jana (Author) Sedlák, Ján (Author) Translated title Podanie izotiokyanátu (E-4IB) a cisplatiny vedie ku zmene signalizácie a exportu lyzozómov v nádorovo senzitívnych a na cisplatinu rezistentných ovariálnych bunkách Phys.des. ilustr., obr. Note Bibliogr. odkazy. Res. angl. In Neoplasma. -- ISSN 0028-2685. -- Vol. 56, no. 3 (2009), s. 208-214 Call number C 720 MeSH Subject nádory vaječníkov - patológia izotiokyanáty - použitie terapeutické cisplatina - použitie terapeutické rezistencia lieková apoptóza - účinky liekov bunky nádorové kultivované - účinky liekov lyzozómy Language English Country Slovakia Database ARTICLES Citations [*2] STEHLÍK, P. - PAULÍKOVÁ, Helena - HUNÁKOVÁ, Ľubica. Synthetic isothiocyanate indole-3-ethyl isothiocyanate (homoITC) enhances sensitivity of human ovarian carcinoma cell lines A2780 and A2780/CP to cisplatin. In Neoplasma : journal of experimental and clinical oncology. - Bratislava : AEPress, 2010. ISSN 0028-2685, 2010, vol. 57, no. 5, s. 473-481.
[*2] DURAJ, J. - PASTOREK, M. - VITKOVSKÁ, J. - CHOLUJOVÁ, Danka - GRONESOVÁ, P. - HUNÁKOVÁ, Ľubica - SEDLÁK, Ján. Proteasome inhibition leads to altered signaling in the proteome of cisplatin-resistant human ovarian carcinoma cell line. In Neoplasma : journal of experimental and clinical oncology. - Bratislava : AEPress, 2013. ISSN 0028-2685, 2013, vol. 60, no. 6, s. 627-634.
article
Number of the records: 1